Goldman Sachs Maintains Buy on Aptiv, Lowers Price Target to $61

Benzinga · 3d ago
Goldman Sachs analyst Mark Delaney maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $71 to $61.